Ads
related to: drugs, brain developmentbrightbrain.com has been visited by 10K+ users in the past month
Search results
New menopause drugs treat hot flashes, but women may face insurance hurdles
NBC NEWS· 5 days agoNew drugs to treat debilitating menopause symptoms — namely hot flashes — are finally on the market...
UNCG and A&T receive funding for research development of drugs for neurological disorders
WXII-TV Winston-Salem· 5 hours agoTwo local universities will get nearly a million dollars for research at the joint School of...
CNS Pharmaceuticals (NASDAQ: CNSP) CEO to Present at 2024 Healthcare Company Showcase
Digital Journal· 14 hours agoThe company today announced that its Chief Executive Officer...Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug
Neuralink to test brain implant on second patient
Axios· 1 day agoThe Food and Drug Administration has cleared Neuralink to implant its brain chip in a second patient after the company reportedly outlined fixes to an...
Simcere Phar-maceuticals Presented Six Studies on Sanbexin® at ESOC 2024
WFRV 5 Green Bay· 22 hours agoSanbexin®, the only Class 1 innovative drug approved worldwide since 2015, has been shown to reduce brain cell damage and dysfunction caused by ischemia ...
Brain 'assembloids': Researchers develop first human mini-brain with fully functional blood-brain...
Medical Xpress· 2 days agoThis major advance, published May 15 2024, in Cell Stem Cell, promises to accelerate the understanding and improve treatment of a wide range of brain disorders, including ...
Revealed: How cod liver oil could be bad for your health
Daily Telegraph· 7 hours agoCod liver oil may be bad for your health, a new study suggests. Research on more than 400,000 adults...
US FDA Clears Neuralink's Brain Chip Implant in Second Patient: Report
Gadgets 360· 2 days agoThe US Food and Drug Administration has allowed billionaire Elon Musk's Neuralink to implant its brain chip in a second person after the company offered ...
Fulgent Announces Second Drug in Development and New Prenatal Genetic Test
Los Angeles Business Journal· 2 days agoEl Monte-based genetic testing and analysis company Fulgent Genetics Inc., which rode the Covid...
IBEX011, the first Nagoya-compliant GMP iboga extract, is now available for clinical use and...
Rome Sentinel· 2 days agoToday, Terragnosis Inc., a Canadian drug development company, announced IBEX011, the first GMP...